R&D Center

We make a better future.

R&D Center

Invitros R&D Center

Invitros R&D Center is committed to building a safe and healthy future through creativity and continuous innovation.
We strive to explore cutting-edge technologies that enhance quality of life, secure new growth opportunities, and develop groundbreaking products.
Our mission is to evolve into a global research hub that delivers new value for the future

History of R&D Center

20202024

Extraction-free PCR
State-of-the-art technology
for In Vitro Diagnostics

2024
  • 2024 Developing a new allergy diagnostic kit that includes multiple rare allergens (MAST) (2023~)
  • Developing a real-time PCR product for simultaneous detection of tuberculosis, non-tuberculous mycobacteria, MAC, and MABC (2023~)
2022
  • Diversification of specimen types of nucleic acid extraction system
  • Developed COVID-19 IGRA blood collection tubes (Roche exclusive)
2021
  • Developed extraction-free real-time PCR diagnostic technology
2020
  • Developed the technology to diagnose the largest number of individual allergens in Korea
20102019

Nucleic Acid Extraction
IGRA-based LTBI Detection
Chemiluminescent
Immunoassay

2017
  • Developed "the world's first" CLIA-based latent tuberculosis diagnostic technology
2016
  • Developed IGRA-based latent tuberculosis diagnostic technology
2015
  • Developed SPRI-based high-purity nucleic acid extraction and purification technology
  • Developed CLIA-based immunodiagnostic device
2014
  • Developed the technology to diagnose the most allergy antigens in South Korea
2013
  • Developed fully automated device for allergy diagnostics
2012
  • Developed multiplex real-time RT-PCR-based multiple respiratory virus diagnostic technology
  • Developed CLIA platform technology
  • Developed line blot-based genetic identification technology for tuberculosis and non-tuberculous mycobacteria
2010
  • Won the R&D Win-Win Cooperation Excellence Award
  • Developed line blot-based diagnostic technology for multi-drug resistant tuberculosis genes
20002009

Real-time PCR
Multiple allergen
simultaneous test

2009
  • Developed Real-time PCR-based quantitative diagnostic technology for hepatitis B
2008
  • Conducted a protein chip technology development project of the Ministry of Education, Science, and Technology
  • Developed line blot-based multiplex allergy antigen diagnostic technology
2007
  • Developed Real-time PCR-based simultaneous diagnostic technology for tuberculosis and non-tuberculous mycobacteria
2005
  • Developed ELISA-based diagnostic technology for HIV antibodies
2001
  • Won the IR52 Jang Young Sil Award in the public sector for malaria anti P.v antibodies
2000
  • Developed "South Korea's first" ELISA-based diagnostic technology for malaria antibodies
19861999

ELISA Diagnostic kit

1991
  • Developed ELISA-based diagnostic technology for C-type antibodies
1986
  • Began research on diagnostic reagents